Furthermore, knockdown of NEK1 by siRNA inhibited glioma cell growth and increased susceptibility to temozolomide (TMZ), the main chemotherapeutic drug used to treat glioma, leading to apoptosis. The gene discussed is NEK1; the disease is central nervous system cancer.